fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

People with opioid use disorder less likely to receive palliative care at end of life

Written by | 4 May 2024

Compared with people without opioid use disorder, those with opioid use disorder were less likely to receive palliative care in clinics and in their homes, and were dying… read more.

UK researchers lead study identifying varied factors in buprenorphine users and urine drug testing

Written by | 5 Nov 2023

A study by a team of researchers across the country, including two from the University of Kentucky, is the first to demonstrate a connection between the characteristics of… read more.

Higher buprenorphine doses associated with improved retention in treatment for opioid use disorder

Written by | 24 Sep 2023

Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a… read more.

Brixadi extended-release subcutaneous injection receives FDA approval for moderate to severe opioid use disorder – Braeburn

Written by | 30 May 2023

Braeburn announces that the FDA has approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (CIII), a new weekly and monthly medication for moderate to severe opioid use disorder… read more.

Overdose deaths involving buprenorphine did not proportionally increase with new flexibilities in prescribing

Written by | 25 Jan 2023

The proportion of opioid overdose deaths involving buprenorphine, a medication used to treat opioid use disorder, did not increase in the months after prescribing flexibilities were put in… read more.

Pharmacists can start patients on road to recovery from opioid use disorder

Written by | 14 Jan 2023

A study from researchers at Brown University, Rhode Island Hospital and the University of Rhode Island found that pharmacists — not just physicians at clinics and doctor’s offices… read more.

Half of patients in telemedicine program for opioid use disorder current with medication a month later

Written by | 25 Nov 2022

More than half of the patients who were prescribed medication to treat opioid use disorder through a virtual program established during the pandemic continued with their treatment at… read more.

Survey shows majority of physicians favor allowing telehealth to treat opioid-use disorder

Written by | 16 Oct 2022

A survey of more than 1,000 registered physicians who used telehealth services to treat patients with opioid-use disorder during COVID-19 found that an overwhelming majority favor making telehealth… read more.

New guidance for cancer pain and opioid use disorder or opioid misuse

Written by | 6 Jul 2022

Opioids are a cornerstone of cancer pain management, but there is a lack of consensus on how to treat pain in cancer patients who also have struggled with… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.